Results 31 to 40 of about 578 (168)

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. [PDF]

Allergy
ABSTRACT This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and ...
Zuberbier T, Ansari ZA, Abdul Latiff AH, Abuzakouk MM, Agcaoili-De Jesus MS, Agondi RC, Al-Ahmad M, Alangari AA, Alhameli H, Alonso Bello CD, Alshareef S, Al-Tamemi S, Altrichter S, Al Wahshi H, Aquilina S, Araújo M, Arnaout R, Asero R, Ballmer-Weber B, Bangert C, Bauer A, Ben-Shoshan M, Bernstein JA, Bindslev-Jensen C, Bizjak M, Boccon-Gibod I, Bonnekoh H, Bouillet L, Brockow K, Brzoza Z, Bulatović Ćalasan M, Bulkhi A, Buttgereit T, Bygum A, Caballero T, Calderon O, Campos R, Cancian M, Carne E, Castor MA, Cerecedo I, Çetinarslan T, Cherrez-Ojeda I, Chkhikvadze N, Chong-Neto HJ, Choo K, Christoff G, Chu CY, Ciupka K, Conlon N, Costa C, Craig TJ, Criado P, Criado P, Danilycheva I, Darlenski R, De Arruda Chaves E, de Montjoye L, Doutre MS, Du-Thanh A, Ebo D, Elkhalifa S, Elmariah S, El-Shanawany T, Ensina LF, Ertaş R, Fachini Jardim Criado R, Ferrer M, Ferrucci S, Fok JS, Fomina D, Fonacier L, Fouda G, Francescantonio I, Fukunaga A, Galvan Calle CA, Garcia E, Gáspár K, Gelincik A, Geng S, Godse K, Gonçalo M, Gotua M, Grattan C, Grosber M, Guidos Fogelbach G, Guilarte M, Guillod R, Hamelmann E, Hawkes J, Hayama K, Heuer R, Hide M, Hoetzenecker W, Inomata N, Kang HR, Kaplan AP, Kapp A, Karam M, Kasperska-Zajac A, Katelaris CH, Kessel A, Khoshkhui M, Kim B, Kinaciyan T, Kocatürk E, Kolacinska-Flont M, Kolkhir P, Konstantinou GN, Kosnik M, Krasowska D, Kulthanan K, Kumaran MS, Kuprys-Lipinska I, Labrador M, Larco JI, Larenas-Linnemann D, Latysheva E, Lazaridou E, Li PH, Lima H, Lippert U, Magerl M, Makris M, Alves Marcelino J, Marzano AV, Medina I, Meshkova R, Micallef D, Mohammed Ali R, Mortz CG, Munoz M, Oude Elberink HNG, Nakonechna A, Nasr I, Nast A, Netchiporouk E, Nettis E, Nieto S, Ogueta Canales I, Okas TL, Orfali RL, Özkaya E, Parisi C, Pennitz A, Pawankar R, Pereira MP, Peter J, Petkova E, Pigatto PD, Podder I, Popov T, Porebski G, Pyatilova P, Ramon GD, Ratti Sisa HA, Recto MS, Ress K, Ridge K, Riedl M, Ritchie C, Rosario Filho N, Rosmaninho I, Rudenko M, Rukhadze M, Rutkowski K, Sabato V, Sahiner UM, Saini S, Saleh Al Sabbagh F, Salman A, Salvo F, Sanchez J, Santucci A, Schliemann S, Schmid-Grendelmeier P, Sekerel BE, Serpa F, Sheikh F, Sheikh J, Shendi H, Siebenhaar F, Sonomjamts M, Soria A, Sousa Pinto B, Staevska M, Staubach P, Stephan M, Stevanovic K, Stingeni L, Stobiecki M, Su Küçük Ö, Sussman G, Szegedi A, Takahagi S, Tanaka A, Teovska Mitrevska N, Thomsen SF, Toubi E, Tsatsou F, Turk M, Vadasz Z, Valerieva A, Valle S, Doorn MV, Veleiro Perez B, Vera Ayala CE, Vestergaard C, Vieira RJ, Maruta CW, Wedi B, Werner RN, Yap EWY, Xepapadaki P, Xiang YK, Ye YM, Yong P, Yosipovitch G, Zalewska-Janowska A, Zeyen C, Zhao Z, Metz M, Giménez-Arnau AM.   +222 more
europepmc   +2 more sources

Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature

, 2021
Omalizumab is a safe and effective treatment option for chronic spontaneous urticaria (CSU). Although cohort studies in patients with asthma show no increased risk of congenital abnormalities, very little data exist in the literature regarding the use of
AKTAŞ, MERYEM, SALMAN, ANDAÇ, Andac Salman, Meryem Aktaş   +3 more
core   +1 more source

Clinico-Epidemiologic Profile and Response to Levocetirizine in Chronic Spontaneous Urticaria: A Retrospective Cohort Study from a Tertiary Care Center in North India. [PDF]

Indian Dermatol Online J
Background: Comprehensive long-term follow-up data regarding chronic spontaneous urticaria (CSU) among general populations, especially from the Indian subcontinent is scanty.
Ashraf R, Bishnoi A, Mehta H, Parsad D, Kumaran MS.   +4 more
europepmc   +2 more sources

Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry. [PDF]

Arch Dermatol Res
Abstract Secukinumab is a fully human IgG1 antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A. Secukinumab is an effective and well-tolerated treatment for plaque psoriasis.
Papp KA, Gooderham M, Lynde C, Brassard D, Al-Mohammedi F, Prajapati VH, Delorme I, Albrecht L, Haydey R, Alam MS, Beecker J, Siddha S, Maguin M, Farag MS, Vieira A, Rihakova L, Langley RG.   +16 more
europepmc   +3 more sources

An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria

, 2022
Background: Guidelines recommend standard doses of antihistamines as first-line, and updosing of antihistamines as second-line treatment for the management of chronic urticaria (CU). However, remission rates with different types of first- and second-line
Kocatürk, Emek, Cihan Orcen, Emek Kocaturk, Ayse Ornek, Sinem, Martin K. Church, Örçen, Cihan, Sinem Ayse Ornek, Church, Martin K.   +7 more
core   +1 more source

Up-dosing of non-sedating antihistamines in chronic urticaria: Need for well-designed clinical trials in India

Perspectives in Clinical Research, 2014
Urticaria is a heterogeneous group of diseases. Chronic urticaria significantly impacts quality-of-life of patients. Second generation, non-sedating antihistamines are recommended as first line treatment for chronic spontaneous urticaria.
Anant D Patil
doaj   +1 more source

Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.

PLoS ONE, 2012
BackgroundCytotoxic T lymphocyte associated antigen-4 (CTLA-4) is involved in the activation pathways of T lymphocytes. It has been shown that the circulating form of CTLA-4 is elevated in patients with hymenoptera allergy and can be down regulated by ...
Anna Maria Riccio, Daniele Saverino, Giampaola Pesce, Anthi Rogkakou, Maurizio Severino, Patrizia Bonadonna, Erminia Ridolo, Marina Mauro, Giorgio Walter Canonica, Marcello Bagnasco, Giovanni Passalacqua   +10 more
doaj   +1 more source

A Prospective Randomized Non-Blinded Study of Safety and Efficacy of Bilastine Up-Dosing (40 mg) Versus Combination of Bilastine 20 mg With Levocetirizine 5 mg in the Treatment of Chronic Spontaneous Urticaria

Indian Journal of Dermatology
Introduction: Chronic spontaneous urticaria (CSU) is the most commonly diagnosed skin condition in dermatology outpatient departments. Second-generation antihistamines are shown to be effective in the control of CSU.
Boggarapu Sneha, Murali Narasimhan, Priya Cinna T. Durai, Ramachandran Ramakrishnan   +3 more
doaj   +1 more source

Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial. [PDF]

Clin Transl Allergy
BACKGROUND: Immunoglobulin E (IgE) and immunoglobulin G4 (IgG4) to peanut and its components may influence the clinical reactivity to peanut. Allergen-specific immunotherapy is known for modifying both IgE and IgG4.
Nilsson C, Vereda A, Borres MP, Andersson M, Södergren E, Rudengren M, Smith A, Simon RJ, Ryan R, Fernández-Rivas M, Adelman D, Vickery BP.   +11 more
europepmc   +2 more sources

Oral immunotherapy for food allergy in children: is it worth it? [PDF]

, 2022
Introduction: Oral immunotherapy (OIT) is effective at inducing desensitization in food-allergic individuals, and is a valid therapeutic option for those allergic to peanut, cow’s milk and egg.
Nagendran, S, Patel, nandinee, Turner, Paul, Sharanya Nagendran, Paul J Turner, Nandinee Patel   +5 more
core   +1 more source